Form 4: Waters Corp CFO Amol Chaubal Receives Equity Awards

Waters Corp's SVP & Chief Financial Officer, Amol Chaubal, received grants of restricted stock units and stock options, aligning his incentives with long-term company performance.

Summary

• Amol Chaubal, SVP & Chief Financial Officer of Waters Corp, was granted equity awards on February 25, 2026.
• The awards include 1,455 Restricted Stock Units (RSUs) and stock options for 7,125 shares of common stock.
• Both the RSUs and stock options will vest in four equal annual installments, with the first installment vesting on February 25, 2027.
• Vesting is contingent upon Mr. Chaubal's continued service with Waters Corp on each vesting date.
• The stock options have an exercise price of $319.44 per share and an expiration date of February 25, 2036.
• Following these transactions, Mr. Chaubal beneficially owns 8,505.393 shares of common stock and 7,125 stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive commitment and aligns management's financial interests with the company's long-term performance through equity incentives.

Positives

• The grant of equity awards to a key executive like the CFO aligns management's financial interests with the long-term performance of Waters Corp and its shareholders.
• The multi-year vesting schedule incentivizes continued service and sustained focus on company growth and value creation.

Future Outlook

The equity grants, with their multi-year vesting schedule extending to February 25, 2027, and beyond, indicate a long-term commitment from the CFO and align his future financial incentives with the sustained performance and growth of Waters Corp.

Industry Context

StockSavvy.ai notes that equity grants are a standard practice in executive compensation across industries, designed to incentivize long-term performance and align executive interests with those of shareholders. This grant to Waters Corp's CFO is consistent with typical compensation structures for senior executives in the life sciences and analytical instruments sector.

Comparison to Industry Standards

• Equity grants, including Restricted Stock Units (RSUs) and stock options, are a common component of executive compensation packages across publicly traded companies, particularly in the technology and life sciences sectors.
• Similar RSU and stock option grants are observed at companies like Thermo Fisher Scientific (TMO) and Agilent Technologies (A) for their senior executives, typically tied to multi-year vesting schedules and performance metrics.
• The mechanism of granting equity with service-based vesting is standard practice, aiming to retain key talent and motivate performance over several years.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the CFO's financial interests with the company's long-term performance and shareholder value creation.

Next Steps

• The first installment of Restricted Stock Units and stock options will vest on February 25, 2027.
• Subsequent installments of the granted equity awards will vest annually thereafter, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a senior executive, which is a standard component of executive compensation. While it indicates continued commitment from management and aligns their interests with shareholders, it does not present new information that would fundamentally alter the investment thesis for Waters Corp. Therefore, a 'hold' recommendation is appropriate as it doesn't provide a strong catalyst for a 'buy' or 'sell' decision based solely on this filing.

Keywords

Waters Corp, WAT, Amol Chaubal, SEC Form 4, Equity Grant, Restricted Stock Units, Stock Options, Executive Compensation, Insider Transaction